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Background: This retrospective study compared the clinicopathological results among three groups divided by
time sequence to evaluate the impact of introducing laparoscopic surgery on long-term oncological outcomes for
right-sided colon cancer.
Methods: From April 1986 to December 2006, 200 patients who underwent elective surgery with stage II and III
right-sided colon cancer were analyzed. The period for group I referred back to the time when laparoscopic
approach had not yet been introduced. The period for group II was designated as the time when first laparoscopic
approach for right colectomy was carried out until we overcame its learning curve. The period for group III was the
period after overcoming this learning curve.
Results: When groups I and II, and groups II and III were compared, overall survival (OS) did not differ significantly
whereas disease-free survival (DFS) in groups I and III were statistically higher than in group II (P= 0.042 and
P= 0.050). In group III, laparoscopic surgery had a tendency to provide better long-term OS (P= 0.2036) and DFS
(P= 0.2356) than open surgery. Also, the incidence of local recurrence in group III (2.6%) was significantly lower
than that in groups II (7.4%) and I (12.1%) (P= 0.013).
Conclusions: Institutions should standardize their techniques and then provide fellowship training for newcomers
of laparoscopic colon cancer surgery. This technique once mastered will become the gold standard approach to
colon surgery as it is both safe and feasible considering the oncological and technical aspects.
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Colorectal cancer, the second most common cancer in
Korea, has been increasing exponentially probably due to
Westernized dietary habits. After the first laparoscopic
colon resection was reported by Jacobs et al. [1] in 1991
many articles were published about the feasibility of laparo-
scopic surgery. Then, numerous articles acclaimed laparo-
scopic surgery for its short-term benefits despite the long
operation time. Recently, articles from multicenter trials
suggested that long-term outcome of laparoscopic surgery
was not inferior to that of open surgery [2-5]. Although
many data are yet to be statistically validated, results tend
to show that advantages of laparoscopic surgery outweigh* Correspondence: jgkim@catholic.ac.kr
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reproduction in any medium, provided the orthose of open surgery [6-8]. It is imperative to overcome
the learning curve (LC) of laparoscopic surgery but once
conquered, laparoscopic surgery appears to be a more de-
sirable procedure with numerous benefits. In our institu-
tion, we introduced laparoscopic surgery in 1991 and have
performed laparoscopic colon surgery since 1994 to the
present. This procedure has now become a standard surgi-
cal procedure for colon cancer in our institute and this has
led us to observe whether long-term oncological outcome
of laparoscopic colon cancer surgery was comparable to
that of open surgery. Moreover, we were curious to find out
the short- and long-term consequences of the LC.
At our institute we gathered 21 years of data to evaluate
the long-term oncological impact of introducing the laparo-
scopic approach in right-sided colon cancer surgery and to
propose whether laparoscopic surgery should replace open. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 This graph shows the learning curve (LC) for
laparoscopic right-sided colon cancer surgery using CUSUM
analysis (target value = 0.009). The LCs of laparoscopic right-sided
colectomy in all TNM stage had been overcome after the 18th
laparoscopic right-sided colectomy.
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method in the area of colorectal surgery.
Methods
In total, 218 patients revealing pathologic stage II or III
of right-sided colon cancer who underwent curative re-
section at the Department of Surgery, St. Vincent’s Hos-
pital, The Catholic University of Korea from April 1986
to December 2006 were evaluated retrospectively. Of
those, 18 patients who underwent emergency operation
for cancer perforation or obstruction were excluded.
After obtaining the review board approval from our in-
stitute, demographics and tumor stages of 200 patients
who underwent elective surgery were identified. For our
study, we defined right-sided colon cancer as a con-
firmed adenocarcinoma arising from the cecum, ascend-
ing colon, hepatic flexure colon, or proximal transverse
colon. We performed right hemicolectomy (RHC) or
extended right hemicolectomy (ERHC) for right-sided
colon cancer. In the case of lymph node dissection, high
vessel ligation that involved ligating the vessel root of
ileocolic artery and mid colic artery in ERHC or ligating
the right branch of mid colic artery and the root of ileo-
colic artery in RHC was referred to as D3. Low vessel
ligation that involved ligating the vessel around marginal
artery was designated as D2.
We divided our patients into three separate groups
according to time sequence. Group I referred back to
the time when laparoscopic approach had not yet been
introduced. Group II was designated as the time when
first laparoscopic approach for right-sided colectomy
was carried out until its LC was overcome. Group III
was the period after overcoming this LC. For the LC of
laparoscopic right-sided colectomy in our institute, we
used the CUSUM model for surgical outcomes. For
CUSUM charts, the observed score for successful
laparoscopic surgery was defined as 0, and the score for
conversion, intraoperative complications, postoperative
complications, or lymph node retrieval of less than 12
from the acquired specimen from surgery were identified
as 1. Also, the mean value of our series (=0.09) was used
as the expected score for the CUSUM charts. With the
CUSUM analysis, we found that the LC of laparoscopic
right-sided colectomy in all TNM stages had been over-
come after the 18th laparoscopic right-sided colectomy
(Figure 1). Since the introduction of laparoscopic pro-
cedure, the same surgical methods were used even dur-
ing open surgery. Thus when dividing the groups, both
open and laparoscopic surgeries were included. There-
fore, 58 patients enrolled in group I, 27 patients in group
II, and 115 patients in group III. In the period of group
II, we defined this period from the very first laparoscopic
right-sided colon cancer surgery to the 18th laparoscopic
operation, but this includes open surgeries as well inbetween. By running CUSUM analysis to obtain the LC
of laparoscopic right-sided colon cancer for all TNM
stages, we found that the LC was 18 cases in order to
perform the surgery with a comparable level of effi-
ciency. However, the subjects of this study were only
patients with stage II and III right-sided colon cancer, so
only 12 out of 18 patients were allocated to group II.
Thus, in group II, 15 patients underwent open surgery
and 12 patients underwent laparoscopic procedure. In
group III, 34 patients underwent open surgery and 81
patients underwent laparoscopic surgery. We had kept
the indication of laparoscopic colon cancer surgery for
all stages except for the stage T4 cancer with severe in-
vasion to adjacent organ. However during early period,
higher costs were required for laparoscopic surgery than
open surgery since laparoscopic surgery was not covered
by the health insurance system in Korea at that time.
For this reason, we discussed laparoscopic surgery in de-
tail with group II patients and its high costs and whether
they preferred to receive open or laparoscopic surgery.
Therefore, we believe the number of patients who
underwent laparoscopic surgery in group II was smaller
than those who had open surgery. Since laparoscopic
surgery’s benefits started to become recognized and be-
came partially covered by the health insurance system in
Korea, the number of cases increased. Still, there are
patients with financial issues who cannot afford non-
deductable disposable instruments such as Ligasure
(Covidien, Mansfield, MA, USA) or Harmonic Scalpel
(Ethicon Endo-Surgery, Cincinnati, OH, USA) opting
patients to have open surgery. This describes the reason
for the number of patients in group III having open
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dication of laparoscopic or open surgery, it was the pa-
tient who decided which operative method to receive,
not their disease condition. Hence, the oncological out-
come was analyzed in each group. In addition, in groups
II and III oncological outcome was compared between
open and laparoscopic surgery.
In order to rule out unnecessary bias we needed to ob-
serve whether clinicopathological features were evenly
distributed in each group. The risk factors that might
have been associated with the oncological outcome were
age, gender, body mass index (BMI), American Society
of Anesthesiologists (ASA) physical status, tumor loca-
tion, operative approach method, range of lymph node
dissection, pathologic stage using UICC system, patho-
logic T and N status, microscopic differentiation, num-
ber of retrieved lymph nodes, whether chemotherapy
was performed or not, whether reoperation was carried
out or not, and preoperative or postoperative serum car-
cinoembryonic antigen (CEA) level.
One-way ANOVA for continuous variables and Chi-
square test for categorical variables were used for com-
paring the clinicopathological features among three
groups. Continuous variables are expressed as the
mean ± standard error. The survival probability analysis
was performed using the Kaplan-Meier method. The
log-rank test was used to assess the difference of survival
between strata. The Cox proportional-hazards regression
model with forward selection was used for multivariate
analysis with statistical significance accepted at P< 0.05.
The applied statistical software was SPSSW 12.0 (SPSS
Inc., Chicago, IL, USA), while CUSUM model was ana-
lyzed using MinitabW 14.0 (Minitab Inc., State College,
PA, USA).
Results
The patients’ ages ranged from 25 to 87 years, with a
mean age of 61.9 ± 12.6 years. A comparison of pre-
operative and postoperative risk factors among the three
groups is shown in Table 1. As time passed, the laparo-
scopic approach was more frequently applied to right-
sided colon cancer surgery. Becoming accustomed to the
laparoscopic approach, high vessel ligation with D3
lymph node dissection was more frequently performed
(P<0.001). Although longer operation times were
needed in groups II and III than in group I, better short-
term outcomes in postoperative complication and post-
operative recovery were observed in group III than in
group I (Table 1).
Figure 2a shows the overall survival (OS) rate of all
patients in the present study. The mean OS was
156.5± 9.6 months. The 5- and 10-year OS rates were
74.1% and 58.9%, respectively. There was no significant
difference in OS among the three groups (P= 0.655,Figure 2b). Unfavorable risk factors that influenced OS
were advanced stage, deep invasion and lymph node in-
volvement, lymphovascular and perineural invasion, less
than 12 lymph nodes retrieval, no adjuvant chemotherapy,
reoperation, and higher level of pre- and postoperative
CEA. Figure 3a shows the disease-free survival (DFS) rate
of all patients in the present study. The mean DFS was
223.4± 8.3 months. The 5- and 10-year DFS rates were
79.8% and 77.2%, respectively. There was no significant
difference in DFS among the three groups (P=0.102).
However, when DFS between two groups were compared,
the DFS rate in group II was lower than that in group I
(P=0.042) and group III (P=0.050) (Figure 3b). Unfavor-
able factors influencing DFS were advanced stage, deep in-
vasion and lymph node involvement, lymphovascular and
perineural invasion, less than 12 lymph nodes retrieval,
and higher level of preoperative CEA. In multivariate ana-
lysis, lymphatic invasion (P=0.005 and P< 0.001), venous
invasion (P=0.001 and P< 0.001), preoperative serum
CEA level (P=0.031 and P< 0.001), and the retrieval of
<12 lymph nodes (P=0.031 and P< 0.001) were inde-
pendent risk factors associated with OS and DFS in stage
II and III right-sided colon cancer. Of these, venous inva-
sion was the most potent independent risk factor asso-
ciated with both OS and DFS (Table 2).
For identifying the safety of laparoscopic surgery, in
groups II and III oncological outcome was compared be-
tween the open and laparoscopic surgery groups. In group
II, comparison between the laparoscopic surgery group and
the open surgery group showed no difference in OS
(P=0.731) and DFS (P=0.677) was observed (Figure 4a
and Figure 4b). However, in group III, although not signifi-
cant statistically, the laparoscopic surgery group had a ten-
dency to provide better long-term OS (P=0.204) and DFS
(P=0.236) than the open surgery group (Figure 4c d).
Table 3 shows the univariate and multivariate analysis
for risk factors of local recurrence in our series. All local
recurrences in our series occurred within 60 months
after surgery for primary lesion. Since the application of
the laparoscopic approach for right-sided colon cancer
surgery, the incidence of local recurrence decreased
(P= 0.013). The incidence of local recurrence was signifi-
cantly lower in patients who underwent high vessel
ligation (P= 0.032) and the retrieval of more than 12
lymph nodes (P= 0.044). Also, poorly differentiated
tumor (P= 0.042) and venous invasion (P= 0.049) were
worse prognostic factors for local recurrence. In multi-
variate analysis, the level of vessel ligation (the range of
lymph node dissection) was the only independent risk
factor for local recurrence.
Discussion
Laparoscopic colon resection has advantages over open
resection in terms of improved early surgical outcomes,








Patient characteristic Age (years) ≤65 38 (66.7%) 16 (59.3%) 52 (45.2%)
>65 19 (33.3%) 11 (40.7%) 63 (54.8%) 0.007
Gender Male 26 (44.8%) 13 (48.1%) 56 (48.7%)
Female 32 (55.2%) 14 (51.9%) 59 (51.3%) 0.641
ASA 1 41 (70.7%) 13 (48.1%) 64 (55.7%)
2 15 (25.9%) 13 (48.1%) 46 (40.0%)
3 2 (3.4%) 1 (3.7%) 5 (4.3%) 0.114
BMI (kg/m2) Mean± S.D. 20.7 ± 3.9 22.4 ± 2.5 22.4 ± 3.3 0.001
Operative procedure Operation method RHC 45 (77.6%) 19 (70.4%) 75 (65.2%)
ERHC 13 (22.4%) 8 (29.6%) 40 (34.8%) 0.096
Approach Open 58 (100%) 15 (55.6%) 34 (29.6%)
Lap - 12 (44.4%) 81 (70.4%) <0.001
Vessel ligation Low 6 (26.1%) 3 (17.6%) 4 (3.7%)
High 17 (73.9%) 14 (82.4%) 103 (96.3%) <0.001
Macroscopic feature Location Cecum 12 (20.7%) 11 (40.7%) 17 (14.8%)
Ascending 25 (43.1%) 9 (33.3%) 57 (49.6%)
H flexure 20 (34.5%) 7 (25.9%) 23 (20.0%)
prox T 1 (1.7%) 0 18 (15.7%) 0.097
Tumor size ≤6.5 34 (58.6%) 17 (63.0%) 61 (53.5%)
>6.5 24 (41.4%) 10 (37.0%) 53 (46.5%) 0.467
Mean± S.D. 6.5 ± 2.6 6.6 ± 3.2 6.6 ± 2.7 0966
Microscopic feature Stage II 40 (69.0%) 18 (66.7%) 64 (56.1%)
III 18 (31.0%) 9 (33.3%) 50 (43.9%) 0.090
Pathologic T 2 2 (3.4%) 1 (3.7%) 2 (1.8%)
3 47 (81.0%) 24 (88.9%) 100 (87.7%)
4 9 (15.5%) 2 (7.4%) 12(10.5%) 0.651
Pathologic N 0 36 (62.1%) 18 (66.7%) 64 (56.1%)
1 15 (25.9%) 5 (18.5%) 31 (27.2%)
2 7 (12.1%) 4 (14.8%) 19 (16.7%) 0.345
Differentiation Well 21 (36.2%) 16 (59.3%) 17 (14.9%)
Moderately 19 (32.8%) 6 (22.2%) 85 (74.6%)
Poorly 11 (19.0%) 3 (11.1%) 9 (7.9%)
Mucinous 7 (12.1%) 2 (7.4%) 3 (2.6%) 0.685
Lymphatic invasion No 10 (35.7%) 15 (62.5%) 88 (77.2%)
Yes 18 (64.3%) 9 (37.5%) 26 (22.8%) <0.001
Venous invasion No 25 (89.3%) 22 (91.7%) 111 (97.4%)
Yes 3 (10.7%) 2 (8.3%) 3 (2.6%) 0.051
Perineural invasion No 25 (86.2%) 22 (91.7%) 97 (85.1%)
Yes 4 (13.8%) 2 (8.3%) 17 (14.9%) 0.708
Retrieved LN <12 4 (6.9%) 10 (37.0%) 22 (19.3%)
≥12 54 (93.1%) 17 (63.0%) 92 (80.7%) 0.103
Additional treatment Adjuvant CTx No 15 (26.3%) 1 (3.8%) 17 (14.9%)
Yes 42 (73.7%) 25 (96.2%) 97 (85.1%) 0.105
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Table 1 Overview of clinical data in 200 patients who underwent right sided colon cancer surgery (Continued)
Perioperative course OP time(mins) Mean± S.D. 199.5 ± 83.4 308.5 ± 109.9 298.7 ± 86.8 <0.001
Intraoperative Cx No 58 (100%) 26 (96.3%) 111 (96.5%)
Yes 0 1 (3.7%) 4 (3.5%) 0.189
Intraoperative TF (mL) Mean± S.D 361.6 ± 636.4 120.4 ± 243.9 83.3 ± 224.8 <0.001
Postoperative Cx No 45 (77.6%) 22 (81.5%) 102 (88.7%)
Yes 15 (22.4%) 5 (18.5%) 13 (11.3%) 0.052
Postoperative TF (mL) Mean± S.D 156.9 ± 362.9 129.6 ± 233.8 164.5 ± 250.7 0.850
Reoperation No 56 (96.6%) 26 (96.3%) 114 (99.1%)
Yes 2 (3.4%) 1 (3.7%) 1 (0.9%) 0.223
ICU stay (days) mean± S.D 4.3 ± 3.9 4.7 ± 3.0 1.9 ± 1.5 <0.001
Hospital stay (days) mean± S.D 23.5 ± 11.4 17.6 ± 4.2 13.9 ± 6.9 <0.001
Serology Preoperative CEA (ng/mL) ≤5 24 (66.7%) 18 (72.0%) 68 (65.4%)
>5 12 (33.3%) 7 (28.0%) 36 (34.6%) 0.790
Postoperative CEA(ng/mL) ≤5 18 (85.7%) 13 (92.9%) 76 (85.4%)
>5 3 (14.3%) 1 (7.1%) 13 (14.6%) 0.818
ASA, American Society of Anesthesiologists; BMI, Body mass index; CEA, Carcinoembryonic antigen; CTx, Chemotherapy; Cx, Complication; ERHC, Extended right
hemicolectomy; H flexure, Hepatic flexure; ICU, Intensive care unit; Lap, Laparoscopic; LN, Lymph node; prox T, Proximal transverse; RH, Right hemicolectomy; TF,
Transfusion.
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ing, shorter length of hospital stay, and lower rate of post-
operative morbidity [6-8]. However, in cancer surgery, the
long-term oncological outcomes appear to be more im-
portant than perioperative outcomes. It has been shown in
several prospective randomized controlled trials that the
long term oncological outcome of laparoscopic surgery in
colon cancer is not inferior to that of open surgery [4,5,8].
Yet, many institutions still contemplate whether or not to
standardize laparoscopic surgery for colon cancer. This
may be due to the steep LC posing as a major challenge
for surgeons with also the fear that the LC will jeopardizeFigure 2 (a) The overall survival rate of stage II and III right-sided col
rate among the three groups.the oncological outcome during the time needed to polish
their craft [9,10].
In respect of long-term oncological outcome, prog-
nostic factors are divided into two categories: factors
related to the tumor itself; and factors relating to the
surgical procedure. Factors related to the tumor itself
are depth of invasion, lymph node metastasis, tumor
differentiation, lymphovascular invasion, and pre-
operative serum CEA level. Factors related to the sur-
gical procedure are adequate resection margin, radical
lymphadenectomy, and adequate lymph node harvest.
Perioperative complications and failure of successfulon cancer patients in this study. (b) Differences of overall survival
Figure 3 (a) The disease-free survival rate of stage II and III right-sided colon cancer patients in the present study. (b) Differences of
disease-free survival rate among the three groups. The disease-free survival rates of groups I and III were statistically higher than that of group II
(P= 0.042 and P= 0.050).
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factors related to the surgical procedure. In our study,
within the factors related to the tumor, we observed
that lymphatic invasion (P = 0.005 and P< 0.001), ven-
ous invasion (P = 0.001 and P< 0.001), and preopera-
tive serum CEA level (P = 0.031 and P< 0.001) were
independent risk factors associated with OS and DFS
in stage II and III right-sided colon cancer. For
patients with above poor prognostic factors, adjuvant
therapy such as chemotherapy may be helpful to im-
prove long-term oncological outcomes. Within the
factors related to the surgical procedure, adequate
lymph node harvest was the only independent prog-
nostic factor related to the surgical procedure
(P = 0.031 and P< 0.001) in both OS and DFS.
The number of harvested lymph nodes may be related
to not only the knowledge of anatomy and the experi-
ence of surgeon but also the accurate pathologic report-
ing system. The number of examined lymph nodes itself
has prognostic value in predicting outcome. The survival
of patients with stage II and III colon cancer has
increased with the increased number of lymph nodes
examined [11]. In the present study, adequate lymph
node harvest was the factor in measuring the LC there-
fore inadequate lymph node harvest was more frequently
found in group II (37.0%) than in group I (6.9%) or
group III (19.3%) (Table 1). These differences in nodal
counts may have risen from inadequate lymphadenect-
omy by a surgeon during the LC period. Also, the DFS
rate in group II was worse than in group I and III
(P= 0.042 and P= 0.050, respectively) (Figure 3b). It
remains to be seen whether differences in nodal counts
among the three groups are clinically meaningful butfrom the data gathered the LC period with fewer lymph
nodes retrieved seems to correlate with low DFS rate.
Ptock et al. [12] demonstrated that conversion of laparo-
scopic colon cancer resection worsens DFS in locally
advanced stage II carcinoma. They especially emphasized
the effect of experience of a surgeon on a successful laparo-
scopic colon cancer resection. A few recent studies showed
that postoperative complication such as anastomotic
leakage was associated with poor survival [13-15].
Tsuchiya et al. [16] demonstrated that factors such as ex-
cessive bleeding, lengthening of operation time, and an in-
crease of surgical manipulation would clearly induce
surgical stress. They suggested that several responses
induced by surgical stress, such as neuroendocrine
responses, cytokine responses, metabolic responses, and
other yet unknown biologic responses, may result in a
marked enhancement of tumor metastasis by affecting re-
sidual or circulating cancer cells or normal host cells in the
target organ or tissue of metastasis. In the period of the LC,
the condition induced to increase the surgical stress such as
conversion or perioperative complication may contribute to
DFS negatively. Also, considering the immunological effect,
longer operation time in group II may affect DFS negatively
[17,18]. Kang et al. [19] demonstrated that technical diffi-
culty during laparoscopy-assisted surgery jeopardizes onco-
logical safety. They insisted that for oncological safety
following laparoscopic assisted surgery, technical difficulty
and the number of procedures performed should be consid-
ered to evaluate the learning process for a laparoscopic sur-
geon. In the early period of our laparoscopic series, we
experienced many technical difficulties. These technical dif-
ficulties resulting from inexperience also may have affected
DFS negatively. Lessening of these risk factors related to
Table 2 Univariate and multivariate analysis for overall survival and disease-free survival in this study














Univariate Multivariate Univariate Multivariate
Group I 86.1 82.5 61.1 87.5 85.6 81.2
II 70.3 66.7 59.3 66.7 62.9 62.9
III 77.2 71.2 64.9 0.655 NS 82.8 81.5 81.5 0.102 NS
Location Cecum 82.1 79.5 63.4 84.6 78.6 78.6
Ascending 79.1 71.9 57.8 81.8 80.3 73.9
Hepatic flexure 77.9 75.6 59.4 81.3 81.3 81.3
Proximal transverse 73.7 66.9 58.6 0.736 NS 78.6 78.6 78.6 0.968 NS
Approach Open 78.3 73.4 57.5 81.6 78.4 75.3
Lap 79.4 74.8 66.3 0.884 82.2 82.2 82.2 0.518 NS}
Vessel ligation Low ligation 76.9 69.2 55.4 69.2 69.2 69.2
High ligation 78.9 74.1 63.8 0.834 NS 83.1 83.1 83.1 0.185 NS
Stage II 87.6 81.8 66.6 89.1 87.9 83.9
III 64.8 61.6 45.5 0.004 NS 69.9 66.2 66.2 <0.001 NS
Pathologic T 2 60.0 60.0 60.0 60.0 60.0 60.0
3 82.4 78.2 62.3 84.3 82.6 80.5
4 56.2 45.4 31.1 0.003 NS 67.3 60.6 52.9 0.015 NS
Pathologic N 0 87.3 81.3 66.9 89.6 88.3 84.1
1 72.4 70.1 48.2 80.9 80.9 80.9
2 55.2 50.6 43.4 0.008 NS 53.1 44.6 44.6 <0.001 NS
Differentiation Well 85.2 79.5 68.5 88.4 84.4 80.7
Moderately 79.9 75.1 50.8 83.3 83.3 83.3
Poorly 60.9 56.2 45.4 65.9 59.9 53.9
Mucinous 72.7 72.7 60.6 0.091 NS 66.7 66.7 66.7 0.025 NS
Lymphatic invasion No 83.9 79.6 63.6 87.4 87.4 87.4
Yes 64.2 59.7 45.3 0.004 0.005 65.4 63.2 63.2 <0.001 <0.001
Venous invasion No 79.7 75.1 58.4 83.6 82.8 82.8
Yes 25.0 25.0 25.0 <0.001 0.001 12.5 12.5 12.5 <0.001 <0.001
Perineural invasion No 80.5 77.1 59.1 82.9 82.9 82.9
Yes 56.5 46.3 46.3 0.029 NS 62.2 55.9 55.9 0.006 NS
Lymph node retrieval <12 58.3 52.5 45.9 62.8 62.8 62.8
≥12 83.3 78.8 62.3 0.012 0.031 85.9 83.4 80.5 0.002 <0.001
Adjuvant CTx No 69.7 62.1 36.5 82.6 82.6 82.6
Yes 80.3 76.1 65.1 0.008 NS 81.4 79.0 75.9 0.621 NS
Reoperation No 79.4 74.5 60.1 82.1 79.9 77.4
Yes 50.0 50.0 25.0 0.041 NS 75.0 75.0 75.0 0.463 NS
Preoperative CEA ≤5 89.1 83.5 68.1 89.8 87.5 82.3
>5 64.7 62.5 49.1 0.003 0.031 68.2 65.2 65.2 <0.001 <0.001
Postoperative CEA ≤5 83.1 77.8 65.1 82.8 80.0 75.8
>5 52.9 52.9 52.9 0.018 NS 64.2 64.2 64.2 0.051 NS
CEA, Carcinoembryonic antigen; CTx, Chemotherapy; NS, Not significant.
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Figure 4 These graphs show the difference of overall survival (OS) and disease-free survival (DFS) between the open surgery group
and the laparoscopic surgery group according to the time sequence. (a) and (b) are graphs for OS and DFS, respectively, in group II; (c) and
(d) in group III.
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deavor of the surgeons.In the LC period, although surgeons
tried to maintain the oncological principle, the no-touch iso-
lation technique fell short in some surgeries, and factors
such as conversion rate, operation time, and perioperative
complications increased in others [9,10,20]. These factors
may all have contributed to the increase in surgical stressbut despite these setbacks, through perseverance and ex-
ploration of numerous techniques, we managed to
standardize right-sided colon cancer surgery using the lap-
aroscopic approach. Firstly, right colic mesentery was lifted
from the retro-peritoneum without touching the colon itself,
focusing on dissecting the mesentery with the diseased
colon. For right colectomy, the ileocolic artery and vein, the






P value P value
Group I 51 (87.9%) 7 (12.1%)
II 25 (92.6%) 2 (7.4%)
III 112 (97.4%) 3 (2.6%) 0.013 0.304
Location Cecum 36 (90.0%) 4 (10.0%)
Ascending 87 (95.6%) 4 (4.4%)
Hepatic flexure 47 (94.0%) 3 (6.0%)
Proximal transverse 18 (94.7%) 1 (5.3%) 0.525
Approach Open 98 (91.6%) 9 (8.4%)
Lap 90 (96.8% 3 (3.2%) 0.146
Vessel ligation Low ligation 11 (84.6%) 2 (15.4%)
High ligation 130 (97%) 4 (3.0%) 0.032 0.019
Stage II 117 (95.9%) 5 (4.1%)
III 70 (90.9%) 7 (9.1%) 0.220
Pathologic T 2 5 (100%) 0
3 162 (94.7%) 9 (5.3%)
4 20 (87.0%) 3 (13.0%) 0.118
Pathologic N 0 113 (95.8%) 5 (4.2%)
1 46 (90.2%) 5 (9.8%)
2 28 (93.3%) 2 (6.7%) 0.355
Differentiation Well 53 (98.1%) 1 (1.9%)
Moderately 104 (94.5%) 6 (5.5%)
Poorly 19 (82.6%) 4 (17.4%)
Mucinous 11 (91.7%) 1 (8.3%) 0.042 0.571
Lymphatic invasion No 108 (95.6%) 5 (4.4%)
Yes 50 (94.3%) 3 (5.7%) 0.711
Venous invasion No 152 (96.2%) 6 (3.8%)
Yes 6 (75.0%) 2 (25.0%) 0.049 0.643
Perineural invasion No 137 (95.1%) 7 (4.9%)
Yes 22 (95.7%) 1 (4.3%) 0.915
Lymph node retrieval <12 31 (86.1%) 5 (13.9%)
≥12 156 (95.7%) 7 (4.3%) 0.044 0.995
Adjuvant CTx No 31 (93.9%) 2 (6.1%)
Yes 154 (93.9%) 10 (6.1%) 0.994
Reoperation No 184 (93.9%) 12 (6.1%)
Yes 4 (100%) 0 0.611
Preoperative CEA ≤5 105 (95.5%) 5 (2.5%)
>5 51 (92.7%) 4 (7.3%) 0.483
Postoperative CEA ≤5 102 (95.3%) 5 (4.7%)
>5 16 (94.1%) 1 (5.9%) 0.595
CEA, Carcinoembryonic antigen; CTx, Chemotherapy.
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right colic artery and vein if present were skeletonized from
their original sites. They were clipped three times at their
original sites and cut between the distal second and third
clip. This allowed the diseased colon and mesentery to be
successfully isolated from the superior mesenteric artery
and vein without injuring or touching other parts of the
colon. Hence, high vessel ligation (D3 lymph node dissec-
tion) was more frequently performed after the introduction
of laparoscopic surgery (Table 1). This division prior to
tumor-containing bowel mobilization could minimize can-
cer cell spread though the draining vessels. The medial to
lateral approach may be more aligned with the no-touch
principle than the lateral to medial approach. Recently,
some reports demonstrated that progress in laparoscopic
techniques for colorectal cancer surgery has resulted in the
development of a medial to lateral approach for D3 lympha-
denectomy [21,22]. Compared with the classical lateral to
medial approach, D3 lymphadenectomy using the medial to
lateral has the advantage of abiding by the no-touch isola-
tion technique for oncologic surgery [21]. Since Turnbull
et al. [23] described the advantage of the no-touch isolation
technique for cancer surgery, many reports demonstrated
better oncological outcome with this technique [24-26].
Hayashi et al. [26] demonstrated that the no-touch isolation
technique could prevent cancer cells from being shed into
the portal circulation during surgical manipulation. Al-
though exact statistical value was not measured, approach
for lymphadenectomy had been mixed to ‘lateral to medial
approach’ and ‘medial to lateral approach’ in group I due to
different policies amongst several surgeons. Since laparo-
scopic surgery was introduced, medial to lateral approach
became the standard procedure for D3 lymphadenectomy
in open as well as laparoscopic colorectal cancer surgery in
our institution. In the present study, with gradually
increased high vessel ligation, the local recurrence rate
decreased gradually in open as well as in laparoscopic sur-
gery after the introduction of laparoscopic surgery
(P=0.013). Also, in multivariate analysis, we found that high
vessel ligation was the only independent prognostic factor
for local recurrence (P=0.019) (Table 3). This finding
appears to result from the endeavor of standardizing the
surgical procedure, including the accomplishment of D3
lymphadenectomy through high vessel ligation and the
medial to lateral approach whilst experiencing the LC in
laparoscopic surgery. With the tendency of better long-term
oncological outcome of laparoscopic surgery shown in
Figure 4, this finding may be considered as the advantage of
laparoscopic surgery through the standardization of the
technique.
In our study, two surgeons performed laparoscopic sur-
gery. The main surgeon, a pioneer in laparoscopic abdom-
inal surgery in Korea, began performing laparoscopic right
sided colon cancer surgery in April 1995. Another surgeon,a junior surgeon, who had experienced laparoscopic surgery
as a scope operator for main surgeon’s laparoscopic proced-
ure beginning in March 2001, began laparoscopic right
sided colon cancer surgery in April 2004. The LC was
based on the results of the main surgeon alone as the corre-
sponding author, (J-G Kim) specializing in colorectal sur-
gery, performed most of the right sided colon cancer
surgeries. Although it is unpublished data, we could ob-
serve that the LC of the junior surgeon did not have an in-
fluence on the oncological outcome. This was because the
junior surgeon began his laparoscopic procedure under
supervision of a pioneer surgeon after the standardization
of the procedure was complete. As shown in Figure 4 and
Table 3, long-term oncological outcomes of laparoscopic
surgery group in group II are not inferior to the open sur-
gery group. In group III, long-term oncological outcomes
of laparoscopic surgery group showed better outcome than
the open surgery group. Some reports suggested that the
standardization of the colorectal cancer surgery would re-
sult in not only the reduction of the LC period but also in
lowering recurrence rate and better OS [10,27]. In our
study, while the procedure during the LC resulted in the
negative effect on DFS, we observed that once the
standardization of the procedure was complete laparo-
scopic surgery had a tendency to provide reduction in re-
currence rate and improved long term oncological
outcome compared to open surgery.
Our study has limitations in that it was a retrospective
study using the medical records of patients, and the fol-
low-up observation could not be performed in all
patients. However, while most reports for the LC of lap-
aroscopic surgery suggested perioperative short-term
outcomes as factors for measuring the LC of laparo-
scopic surgery, our study found that surgical and patho-
logical factors must be considered to measure the LC for
cancer surgery.
Conclusions
The laparoscopic approach for stage II and III right-
sided colon cancer is safe and feasible in both onco-
logical and technical aspects. However, because of the
probability of poor oncological outcomes during the LC
period, surgeons must make great efforts to shorten this
time frame. Institutions should standardize their techni-
ques and then provide fellowship training for newcomers
of laparoscopic colon cancer surgery as this technique
once mastered will become the gold standard approach
to colon surgery.
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